Notice of Intent to Sole Source to Qiagen LLC

The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to

Qiagen LLC for a Roto-Gene Q 6Plex Platform.

The RotorGene Q real-time PCR instrument is used for STD pathogen detection with options for two different reaction tube size allowing from 36 to 72 samples to be run simultaneously. Unlike other real-time PCR instruments which use a microtiter plate format and plates have to be discarded after a single use, the RotorGene Q uses individual tubes resulting in significant reduction in plastic use for testing. The RotorGene Q instrument also has unmatched optical range spanning UV to infrared wavelengths compared to the other instruments.

This contract action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) (SAP) and 10 U.S.C. 2304(c)(1). Interested persons may identify their interest and capability to respond to the requirement or submit proposals. This notice of intent is not a request for competitive quotations; however, all quotations/responses received within five (5) days of the issuance of this notice will be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to Contract Specialist at pyx9@cdc.gov by 5pm EST on 7-14-2020.